CFO sold ~$436K of Gilead Sciences
Scheduled in advanceLoading…
Chief Financial Officer
Disclosures on record
29
Companies involved
1
CFO sold ~$436K of Gilead Sciences
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Routine share withholding; mechanical by default.
CFO sold ~$415K of Gilead Sciences
Scheduled in advanceCFO sold ~$390K of Gilead Sciences
Scheduled in advanceCFO sold ~$376K of Gilead Sciences
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Routine share withholding; mechanical by default.
CFO sold ~$397K of Gilead Sciences
Scheduled in advanceCFO sold ~$423K of Gilead Sciences
Scheduled in advanceCFO sold ~$433K of Gilead Sciences
Scheduled in advanceCompensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Routine share withholding; mechanical by default.
Compensation award — excluded from discretionary-purchase analysis.
CFO sold ~$463K of Gilead Sciences
Scheduled in advanceCompensation award — excluded from discretionary-purchase analysis.
Routine share withholding; mechanical by default.
CFO sold ~$373K of Gilead Sciences
Scheduled in advanceCFO sold ~$366K of Gilead Sciences
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Routine share withholding; mechanical by default.
CFO sold ~$313K of Gilead Sciences
Scheduled in advanceCFO sold ~$295K of Gilead Sciences
Scheduled in advance